Trials / Completed
CompletedNCT04631263
New Dermal Filler for Chin Correction and Augmentation
A Randomized, Evaluator-blinded, Parallel Group, no Treatment Controlled, Multi-center Study to Evaluate Effectiveness and Safety of GP0109 for Augmentation and Correction of Retrusion in the Chin Region
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
Randomized, evaluator-blinded, no treatment controlled multicenter study to evaluate safety and effectiveness of GP0109 for augmentation and correction or retrusion in the chin region in Canada
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hyaluronic Acid | Injectable gel. Chin correction and augmentation for retrusion |
Timeline
- Start date
- 2021-01-29
- Primary completion
- 2021-09-09
- Completion
- 2022-06-16
- First posted
- 2020-11-17
- Last updated
- 2022-08-25
Locations
9 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT04631263. Inclusion in this directory is not an endorsement.